Description
Tirzepatide 10mg – Dual GIP/GLP-1 Agonist for Metabolic and Weight Management Research
Tirzepatide 10mg is a next-generation peptide compound developed for research into blood glucose regulation and body weight management in subjects with type 2 diabetes. Functioning as a dual agonist of both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, Tirzepatide has demonstrated powerful potential in supporting glycemic control and weight reduction.
This compound works by stimulating insulin secretion, reducing glucagon levels, slowing gastric emptying, and curbing appetite—resulting in improved metabolic outcomes in long-term research settings.
Key Features:
-
10mg high-purity lyophilized Tirzepatide peptide
-
Supports healthy blood sugar regulation
-
Promotes weight loss and appetite control
-
Dual-action GIP & GLP-1 receptor agonist
-
Designed for once-weekly administration in clinical research
-
Backed by clinical studies for safety and efficacy insights
⚠️ For Research Use Only. Not for Human Consumption.
This compound is sold strictly for in vitro laboratory research purposes only. It is not intended for human or veterinary use, nor for diagnostic or therapeutic purposes. No claims are made regarding safety or efficacy in any clinical application.Disclaimer:
All information provided is for educational and scientific reference only. Statements have not been evaluated by the FDA or any medical regulatory body. This product is not a drug or supplement. Buyer assumes all responsibility for lawful use and compliance with applicable regulations.Terms of Sale:
By purchasing from LIBERTY LABS, you confirm that you are a qualified researcher or institution equipped to handle this material safely. You accept full responsibility for its use and understand that Liberty Labs assumes no liability for misuse, misinterpretation, or improper application of this compound. ALL SALES FINAL